ID: ALA4792253
Chembl Id: CHEMBL4792253
PubChem CID: 13390008
Max Phase: Preclinical
Molecular Formula: C15H10F3NO3
Molecular Weight: 309.24
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(Nc1ccccc1C(=O)O)c1cccc(C(F)(F)F)c1
Standard InChI: InChI=1S/C15H10F3NO3/c16-15(17,18)10-5-3-4-9(8-10)13(20)19-12-7-2-1-6-11(12)14(21)22/h1-8H,(H,19,20)(H,21,22)
Standard InChI Key: FMHBRBGTIXUXQP-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 309.24 | Molecular Weight (Monoisotopic): 309.0613 | AlogP: 3.66 | #Rotatable Bonds: 3 |
| Polar Surface Area: 66.40 | Molecular Species: ACID | HBA: 2 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 3.55 | CX Basic pKa: ┄ | CX LogP: 4.25 | CX LogD: 0.89 |
| Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.91 | Np Likeness Score: -1.39 |
| 1. Iwaki Y,Yashiro K,Kokubo M,Mori T,Wieting JM,McGowan KM,Bridges TM,Engers DW,Denton JS,Kurata H,Lindsley CW. (2019) Towards a TREK-1/2 (TWIK-Related K+ Channel 1 and 2) dual activator tool compound: Multi-dimensional optimization of BL-1249., 29 (13.0): [PMID:31072652] [10.1016/j.bmcl.2019.04.048] |
Source(1):
